SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%Dec 22 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24488)8/14/1998 12:19:00 PM
From: jayhawk969  Read Replies (1) of 32384
 
I believe that the discussions between SRGN and the FDA are in the private
category and approval will be granted when outstanding administrative are
resolved, which I suspect will be later this quarter. I was under the impression
that SRGN converted to LGND today, but several had indicated that SRGN was
trading today.

According to Ligand Investor Relations it has stopped, However I converted some Ligand for an additional block of SRGN today, through Schwab. Schwab stated this may be the last day of trading. Couldn't resist, I get a tax loss on the LGND sale, and my cost of the SRGN after hedging limits my losses and hopefully sets up a gain with the Ontak approval.

J.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext